ClinicalTrials.Veeva

Menu

National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia

K

King Saud University

Status

Enrolling

Conditions

SLE (Systemic Lupus)

Study type

Observational

Funder types

Other

Identifiers

NCT04604990
E-19-3955/8

Details and patient eligibility

About

SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.

Enrollment

1,000 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult patients defined as age greater than 18 years old.
  2. Patients should fulfil one of the following classification criteria for SLE (ACR, SLICC or ACR/EULAR criteria).
  3. No restriction on time of diagnosis.

Exclusion criteria

  • Patients who don't fulfil classification criteria mentioned above.

Trial design

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Ibrahim Almaghlouth, MSc(c), AmBIM, FRCPC, FACR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems